GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt · Delayed Price · Currency is EGP 65.38
-0.70 (-1.06%)
At close: Apr 23, 2026
GlaxoSmithKline S.A.E Revenue
In the year 2025, GlaxoSmithKline S.A.E had annual revenue of 3.73B EGP with 24.73% growth. GlaxoSmithKline S.A.E had revenue of 837.48M in the quarter ending December 31, 2025, a decrease of -1.18%.
Revenue
3.73B
Revenue Growth
+24.73%
P/S Ratio
1.46
Revenue / Employee
4.66M
Employees
800
Market Cap
5.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.73B | 739.68M | 24.73% |
| Dec 31, 2024 | 2.99B | 750.60M | 33.51% |
| Dec 31, 2023 | 2.24B | 416.99M | 22.87% |
| Dec 31, 2022 | 1.82B | 11.19M | 0.62% |
| Dec 31, 2021 | 1.81B | -180.79M | -9.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition